Results
1 -
6 of
6
(Click
here to explore results)
- Repurposing drugs against the main protease of SARS-CoV-2: mechanism-based insights supported by available laboratory and clinical data. Sohini Chakraborti, Sneha Bheemireddy, Narayanaswamy Srinivasan
, Mol. Omics
, 2020
, 16
, 474
- Ligand identification of the adenosine A2A receptor in self-assembled nanodiscs by affinity mass spectrometry. Jun Ma, Yan Lu, Dong Wu, Yao Peng, Wendy Loa-Kum-Cheung, Chao Peng, Ronald J. Quinn, Wenqing Shui, Zhi-Jie Liu
, Anal. Methods
, 2017
, 9
, 5851
- Design, synthesis and evaluation of N
6-substituted 2-aminoadenosine-5′-N-methylcarboxamides as A3 adenosine receptor agonists. Shane M. Devine, Lauren T. May, Peter J. Scammells
, Med. Chem. Commun.
, 2014
, 5
, 192
- Expanding the repertoire of methanocarba nucleosides from purinergic signaling to diverse targets. Kenneth A. Jacobson, Veronica Salmaso, R. Rama Suresh, Dilip K. Tosh
, RSC Med. Chem.
, 2021
, 12
, 1808
- Incorporating QM and solvation into docking for applications to GPCR targets. Minsup Kim, Art E. Cho
, Phys. Chem. Chem. Phys.
, 2016
, 18
, 28281
- Stabilised G protein-coupled receptors in structure-based drug design: a case study with adenosine A2A receptor. Stephen P. Andrews, Benjamin Tehan
, Med. Chem. Commun.
, 2013
, 4
, 52